Look up a license
Match the name or license number. Check status, expiration, and any restrictions shown.
Washington pharmacist credential search Covers: Select a pharmacist credential rather than a pharmacy facility in the public HELMS search.Washington Board of Pharmacy
Washington pharmacists need 30 hours of continuing education every 2 years. 2 state-mandated topics may apply, depending on the license and practice.
At a glance
| Licenses covered | Pharmacist (RPh) [1] |
|---|---|
| CE required for renewal | Yes [1] |
| Hours per CE period | 30 hours [1] |
| CE period | Every 2 years [2] |
| Renewal and reporting | A pharmacist must complete the equivalent of 30 hours of continuing education each license renewal cycle. [1] |
| State-mandated topics | Health equity; Suicide screening and referral (one time) [1] |
| What CE counts | The 30 hours of continuing education must be delivered by a continuing education provider accredited by ACPE. [1] |
This summary covers the licenses listed above. The topics below are selected verified requirements; consult the board’s full rules for all subjects and conditions.
Complete at least one hour of health equity training each renewal cycle, under WAC 246-12-830.
Complete approved training of at least three hours by the end of the first full renewal cycle after initial licensure.
Rules change, and your own license record decides your deadline. Confirm with the Washington Board of Pharmacy ↗ before you renew.
Your next step
Match the name or license number. Check status, expiration, and any restrictions shown.
Washington pharmacist credential search Covers: Select a pharmacist credential rather than a pharmacy facility in the public HELMS search.A public search may be enough for a status check. Another board or employer may require a verification sent directly by the issuer.
Check verification instructions Confirm the recipient’s required format and any fee.Confirm your due date, complete the required education, and submit to the licensing authority.
Facilities - New, Renew or Update Covers: Washington Board of Pharmacy.| Credential | Pharmacist |
|---|---|
| Renewal cycle | Confirm the cycle and expiration date for your specific license with the board. |
| Verified fees | A current fee has not been confirmed in this guide. Check the board’s fee schedule before paying. |
| Renewal application | Facilities - New, Renew or Update |
Fees can differ for active, inactive, late, and reinstatement applications. Your official license record controls your deadline.
Dates show when we retrieved the source pages. They do not certify a person’s license, guarantee a portal is online, or establish that every renewal rule was reviewed.
Free courses that count toward the hours
The board accepts continuing education accredited by ACPE [1]. These current free courses state that accreditation. State-mandated topics can require a specific approved course, so check those separately.
The pace at which targetable tumor-specific molecular alterations have been identified over the past decade have ushered in an era of precision oncology, yielding significant insights into the diversity of cancer, offering diagnostic and prognostic benefits, and guiding therapy selection. Indeed, guidelines emphasize that comprehensive biomarker testing should be conducted to identify actionable mutations in non-small-cell lung cancer (NSCLC), including ALK, EGFR, KRAS, MET, RET, and ERBB2 (HER2). These tests guide the selection of targeted therapies that can inhibit oncogenic pathways directl
The management of type 2 diabetes (T2D) is complex, requiring a multidisciplinary, patient-centered approach that accounts for individualized glycemic and weight goals, comorbidities, hypoglycemia risk, medication costs, and individual preferences. Therapeutic inertia and patient reluctance often delay insulin initiation and intensification in patients with persistent hyperglycemia despite multiple antihyperglycemic agents. The emergence of once-weekly basal insulin analogues represent a transformative advancement in T2D management, offering a simplified treatment paradigm to address common ba
The management of hormone receptor–positive (HR-positive), human epidermal growth factor receptor 2–negative (HER2-negative) metastatic breast cancer (mBC) is undergoing rapid transformation, largely driven by the imperative to overcome acquired endocrine resistance, frequently mediated by somatic estrogen receptor 1 (ESR1) mutations. These mutations predict a lack of benefit from further aromatase inhibitor (AI) therapy, making the correct identification and subsequent targeting of these alterations critical for guiding treatment selection. Next-generation oral selective estrogen receptor deg
Selecting, intensifying, sequencing, or combining therapies in IBD can be challenging for clinicians, especially considering the number of novel targeted therapies available and the expanding role of patient-reported outcomes in individualization of therapeutic decision-making. Advance your IBD management through implementation of recommended treat-to-target strategies. Start with an individualized assessment to determine the strengths and gaps in your current practice, then review educational content according to your needs. Reinforce your learning through practical guidance (eg, interactive
a statement of participation Target Audience The intended audience for this activity is physicians and nurse practitioners specializing in psychiatry as well as pharmacists who are involved in the management of patients with treatment-resistant depression (TRD). Program Overview Treatment-resistant depression (TRD) presents ongoing challenges for psychiatric clinicians, including delayed recognition, trial-and-error treatment sequencing, and high relapse rates
a statement of participation. Target Audience The intended audience for this activity is physicians and nurse practitioners specializing in psychiatry, as well as pharmacists who are involved in the management of patients with anxiety and/or depression. Program Overview Several psychedelic and psychedelic-adjacent therapies are advancing through late-stage clinical development, expanding the evidence base supporting their efficacy in the management of anxiety a
Health 2.0: Implications for Care. A no-cost NetCE course from the reviewed profession catalog free sections.
2025 SABCS Abstracts to Action: From Data to Decisions in HR+ Breast Cancer Care. A continuing education activity offered by Pharmacy Times Continuing Education.
A Managed Care Perspective on Hard-to-Control Hypertension: Understanding the Risks and Challenges in Uncontrolled and Resistant Hypertension. A continuing education activity offered by Pharmacy Times Continuing Education.
Your next credential
Explore Washington and national exam practice for your profession on OpenExamPrep.
These are exam-preparation resources, separate from continuing education credit. Exam registration fees and eligibility are set by the exam sponsor.
Questions
Washington pharmacists need 30 hours of continuing education every 2 years. 2 state-mandated topics may apply, depending on the license and practice. A pharmacist must complete the equivalent of 30 hours of continuing education each license renewal cycle.
Health equity (1 hours): Complete at least one hour of health equity training each renewal cycle, under WAC 246-12-830. Suicide screening and referral (one time) (3 hours): Complete approved training of at least three hours by the end of the first full renewal cycle after initial licensure.
The 30 hours of continuing education must be delivered by a continuing education provider accredited by ACPE. Free courses accredited by ACPE are listed on this page; a state-mandated topic may need a specific approved course.
Every fact above links to the official page it comes from. We fetched each page on the date shown and confirmed the exact wording below appears on it.
“education in compliance with this section.(2) A pharmacist shall complete the equivalent of 30 hours of continuing education each license renewal cycle. The 30 hours of continuing education must be delivered by a continuing education provider accredited by ACPE, except as provided for in subsections (4) and (5)”
“education in compliance with this section.(2) A pharmacist shall complete the equivalent of 30 hours of continuing education each license renewal cycle. The 30 hours of continuing education must be delivered by a continuing education provider accredited by ACPE, except as provided for in subsections (4) and (5)”
“education in compliance with this section.(2) A pharmacist shall complete the equivalent of 30 hours of continuing education each license renewal cycle. The 30 hours of continuing education must be delivered by a continuing education provider accredited by ACPE, except as provided for in subsections (4) and (5)”
“education. Agency filings affecting this section (1) As part of the process to renew a pharmacist license, a pharmacist shall complete continuing education in compliance with this section.(2) A pharmacist shall complete the equivalent of 30 hours of continuing education each license renewal cycle. The 30 hours of continuing education must be delivered”
“continuing education each license renewal cycle. The 30 hours of continuing education must be delivered by a continuing education provider accredited by ACPE, except as provided for in subsections (4) and (5) of this section.(3) A pharmacist shall register with a program designated by the commission for tracking completed”
“meeting continuing education requirements.(6) Continuing education hours cannot be carried over to the next renewal cycle.[Statutory Authority: 2021 c 276. WSR 24-01-101, § 246-945-178, filed 12/18/23, effective 1/18/24. Statutory Authority: RCW 18.64.005 and 18.64A.020. WSR 21-04-145,”
“A pharmacist shall complete at least one hour of health equity training as described in WAC 246-12-830 each license renewal cycle.(a) Health equity training may be provided by a continuing education provider accredited by ACPE or by a health equity training program contained on the department's list of approved health equity training programs.(b) The hours spent completing health equity training will count toward meeting continuing education requirements.(6) Continuing education hours cannot be carried over to the next renewal cycle.[Statutory Authority: 2021 c 276. WSR 24-01-101, § 246-945-178, filed 12/18/23, effective 1/18/24. Statutory Au”
“A pharmacist shall complete a one-time training in suicide screening and referral by the end of the first full renewal cycle after initial licensure. The training must meet the following requirements:(a) Be at least three hours long;(b) Be from the department's model list of approved suicide prevention training programs, and include content related to imminent harm via lethal means; and(c) The hours spent completing the training in this subsection may count toward meeting CPE requirements.(5) A pharmacist shall complete at least one hour of health equity training as described in WAC 246-12-830 each license renewal cycle.(a) Health equity training may be provided by a continuing education pro”
“credentials must be renewed every two years on the practitioner's birthday as provided in chapter 246-12 WAC.(2) Pharmacy location credentials, controlled substance researcher regi”